sever
acut
respiratori
syndrom
sar
lifethreaten
diseas
caus
novel
coronaviru
term
sarscov
due
sever
diseas
world
health
organ
recommend
manipul
activ
viral
cultur
sarscov
perform
contain
laboratori
biosafeti
level
viru
inactiv
ultraviolet
light
uv
nm
heat
treatment
c
greater
alkalin
ph
acid
ph
condit
formalin
glutaraldehyd
treatment
describ
kinet
effici
viral
inactiv
method
allow
research
sarscov
contain
materi
render
noninfecti
conduct
reduc
safeti
level
late
outbreak
unusu
lifethreaten
respiratori
diseas
unknown
etiolog
began
guangdong
provinc
china
diseas
design
sever
acut
respiratori
syndrom
sar
later
determin
drosten
et
al
ksiazek
et
al
rota
et
al
caus
novel
coronaviru
term
sarscov
sinc
identif
coronaviru
infecti
agent
sar
numer
laboratori
begun
research
viru
accord
peopl
diagnos
sar
peopl
die
diseas
initi
outbreak
due
sever
sar
diseas
contagi
natur
causal
agent
websit
http
provid
guidelin
work
safe
coronaviru
recommend
biosafeti
level
appropri
contain
level
work
live
sarscov
concern
anoth
sar
outbreak
could
occur
follow
accident
exposur
laboratori
sinc
end
sar
epidem
juli
three
known
case
sar
laboratori
research
due
accident
exposur
viru
normil
success
inactiv
viru
allow
transfer
materi
environ
may
reduc
risk
accident
infect
unsaf
laboratori
practic
inactiv
cellcultur
deriv
viral
stock
may
also
use
develop
vaccin
studi
safeti
immunogen
examin
effici
sever
method
viral
inactiv
includ
method
may
inhibit
viral
replic
entri
infect
african
green
monkey
kidney
vero
cell
sarscov
urbani
strain
kindli
provid
dr
lj
anderson
tg
ksiazek
center
diseas
control
prevent
atlanta
ga
briefli
vero
monolay
cell
infect
inocul
cultur
l
viru
tcid
per
ml
final
volum
ml
dulbecco
modifi
eagl
medium
dmem
biosourc
intern
camarillo
ca
flask
h
c
dulbecco
modifi
eagl
medium
contain
supplement
fetal
bovin
serum
mmml
lglutamin
uml
penicillin
gml
streptomycin
gml
fungizon
biosourc
intern
ad
flask
cell
incub
c
day
supernat
collect
clarifi
centrifug
store
c
viral
stock
vero
cell
maintain
dmem
supplement
personnel
wore
power
airpurifi
respir
saint
paul
mn
work
infecti
viru
insid
biosafeti
cabinet
within
contain
facil
viral
titer
determin
vero
cell
monolay
plate
use
tissu
cultur
infecti
dose
assay
tcid
serial
dilut
viru
sampl
incub
c
day
subsequ
examin
cytopath
effect
cpe
infect
cell
describ
ksiazek
et
al
briefli
sarscovinduc
cpe
infect
cell
determin
observ
round
detach
cell
close
associ
evid
inactiv
determin
absenc
cpe
vero
cell
indic
loss
infect
ultraviolet
light
uv
treatment
perform
ml
aliquot
viru
volum
depth
cm
plate
corn
inc
corn
ny
uv
light
sourc
spectron
corpor
westburi
ny
place
plate
distanc
cm
bottom
well
contain
viru
sampl
cm
uvc
light
sourc
nm
emit
wcm
w
js
uva
light
sourc
nm
emit
wcm
measur
radiometr
analysi
spectron
corpor
exposur
uv
light
sourc
viru
frozen
later
analysi
tcid
assay
use
cpe
endpoint
prepar
l
sampl
sarscov
kept
dri
ice
transport
test
sampl
subject
gamma
radiat
rad
co
sourc
control
sampl
protect
exposur
test
control
sampl
handl
transport
ident
except
test
sampl
expos
gamma
radiat
sourc
sampl
kept
frozen
analysi
inactiv
tcid
assay
incub
l
aliquot
viru
ml
polypropylen
cryotub
use
heat
block
achiev
three
differ
temperatur
c
heat
treatment
sampl
frozen
later
analysi
tcid
assay
use
cpe
endpoint
formaldehyd
mallinckrodt
baker
inc
pari
ky
glutaraldehyd
sigma
saint
loui
mo
dilut
steril
pb
dilut
aldehyd
ad
viru
sampl
achiev
final
dilut
l
final
concentr
formaldehyd
final
concentr
glutaraldehyd
viru
aldehyd
sampl
incub
c
day
sampl
mix
briefli
vortex
day
sampl
store
c
analysi
tcid
assay
viru
aliquot
adjust
desir
ph
use
hcl
naoh
subsequ
divid
three
aliquot
incub
desir
temperatur
c
neutral
ph
analyz
viral
titer
use
tcid
assay
infect
vero
cell
prepar
inocul
l
viru
tcid
per
ml
sarscov
final
volum
ml
flask
h
c
dmem
supplement
ad
flask
cell
incub
c
day
monolay
wash
phosphat
buffer
salin
pb
cell
lyse
addit
ml
phenol
guanidin
isothiocyan
solut
trizol
reagent
sigma
cytoplasm
rna
isol
accord
manufactur
specif
vero
cell
inocul
l
purifi
rna
ml
dmem
hour
dmem
supplement
ad
addit
vero
cell
transfect
cytoplasm
rna
use
dmriec
invitrogen
life
technolog
carlsbad
ca
accord
manufactur
instruct
cell
incub
c
observ
cpe
day
examin
infect
detergentdisrupt
virion
sarscov
infect
vero
monolay
cell
wash
dissoci
trypsinversen
pellet
centrifug
wash
pb
centrifug
pellet
lyse
sodium
dodecyl
sulfatenonidet
sd
pb
sigma
frozen
c
thaw
clarifi
centrifug
supernat
use
infect
vero
cell
monolay
plate
final
concentr
sd
three
four
day
follow
inocul
cell
observ
evid
cpe
uv
light
divid
three
classif
uva
nm
uvb
nm
uvc
nm
uvc
absorb
rna
dna
base
caus
photochem
fusion
two
adjac
pyrimidin
coval
link
dimer
becom
nonpair
base
perdiz
et
al
uvb
caus
induct
pyrimidin
dimer
less
effici
uvc
perdiz
et
al
uva
weakli
absorb
dna
rna
much
less
effect
uvc
uvb
induc
pyrimidin
dimer
may
caus
addit
genet
damag
product
reactiv
oxygen
speci
caus
oxid
base
strand
break
tyrrel
et
al
examin
inactiv
potenti
uva
uvc
viru
stock
place
tissu
cultur
plate
expos
uv
irradi
ice
vari
amount
time
indic
fig
exposur
viru
uvc
light
result
partial
inactiv
min
increas
effici
min
fig
result
decreas
infecti
viru
addit
inactiv
observ
min
min
viru
complet
inactiv
limit
detect
assay
tcid
log
per
ml
contrast
uva
exposur
demonstr
signific
effect
viru
inactiv
min
period
data
show
uvc
light
inactiv
sar
viru
distanc
cm
min
standard
procedur
inactiv
virus
manufactur
biolog
product
gamma
irradi
grieb
et
al
investig
effect
gamma
irradi
sarscov
subject
l
sarscov
gamma
radiat
rad
co
sourc
control
sampl
protect
exposur
effect
viral
infect
observ
within
rang
gamma
irradi
exposur
fig
heat
inactiv
virus
denatur
secondari
structur
protein
therebi
may
alter
conform
virion
protein
involv
attach
replic
within
host
cell
leli
et
al
schlegel
et
al
test
abil
heat
inactiv
sarscov
incub
viru
ml
polypropylen
cryotub
three
temperatur
c
increas
period
time
viru
aliquot
l
place
cryovial
dri
ice
expos
indic
dose
gamma
irradi
control
sampl
treat
ident
without
radiat
exposur
sampl
titrat
vero
cell
triplic
dot
line
denot
limit
detect
assay
found
c
viru
inactiv
min
fig
howev
viru
remain
infecti
level
close
limit
detect
assay
least
min
suggest
viru
particl
stabl
c
fig
c
c
viru
inactiv
incub
longer
min
fig
infecti
viru
could
still
detect
close
limit
detect
assay
min
c
viru
incomplet
inactiv
c
even
min
complet
inactiv
c
min
fig
surprisingli
c
viru
inactiv
earli
time
point
min
small
amount
viru
detect
one
possibl
explan
result
may
presenc
subsequ
dissoci
aggreg
taken
togeth
result
suggest
viral
inactiv
pasteur
may
effect
formalin
dilut
formaldehyd
use
number
year
inactiv
viru
use
vaccin
product
wide
use
effect
polio
vaccin
salk
salk
attempt
use
formalin
inactiv
gener
vaccin
respiratori
syncyti
viru
kim
fulgin
et
al
use
induc
aberr
immun
respons
result
formalininduc
perturb
virus
formalin
inactiv
occur
nonproton
amino
group
amino
acid
lysin
combin
formaldehyd
form
hydroxymethylamin
hydroxymethylamin
combin
amino
amid
guanidyl
phenol
imidazol
group
amino
acid
creat
interor
intramolecular
methylen
crosslink
review
see
jiang
schwendeman
fraenkelconrat
observ
absorpt
spectra
sever
plant
virus
determin
formalin
also
bind
revers
manner
rna
block
read
genom
rna
polymeras
glutaraldehyd
also
use
inactiv
viru
use
disinfect
agent
medic
instrument
endoscop
tandon
fix
electron
microscopi
mcdonnel
russel
examin
formalin
glutaraldehyd
inactiv
sarscov
incub
viru
sampl
formalin
glutaraldehyd
two
differ
dilut
dilut
aldehyd
incub
viru
c
aldehyd
exhibit
temperatur
de
tabl
effect
pendenc
abil
inactiv
viru
tabl
neither
formalin
glutaraldehyd
dilut
abl
complet
inactiv
viru
c
even
exposur
day
tabl
c
formalin
inactiv
viru
close
limit
detect
assay
day
yet
viru
still
remain
infecti
day
howev
glutaraldehyd
complet
inactiv
viru
day
c
day
c
suggest
formalin
glutaraldehyd
inactiv
sar
viru
may
effici
method
inactiv
proper
condit
met
weismil
et
al
determin
ph
induc
conform
chang
spike
protein
coronaviru
mous
hepat
viru
mhv
enabl
fusion
virion
host
cell
howev
xiao
et
al
determin
spike
protein
sarscov
mediat
fusion
host
cell
neutral
ph
data
suggest
differ
ph
condit
affect
spike
protein
coronavirus
activ
spike
protein
sarscov
may
sensit
chang
ph
possibl
chang
infecti
natur
viral
particl
therefor
investig
effect
differ
ph
exposur
infect
sarscov
expos
sarscov
extrem
alkalin
condit
ph
h
subsequ
revers
condit
neutral
buffer
solut
viru
complet
inactiv
fig
moder
variat
ph
condit
littl
effect
viru
titer
regardless
temperatur
howev
highli
acid
ph
condit
complet
inactiv
viru
c
c
ph
fulli
inactiv
viru
data
indic
infect
sarscov
sensit
ph
extrem
biochem
molecular
biolog
experi
may
requir
isol
nucleic
acid
protein
viru
fig
effect
ph
condit
infect
sarscov
viru
aliquot
ml
adjust
indic
ph
condit
divid
triplic
sampl
incub
design
temperatur
h
neutral
frozen
titrat
dot
line
denot
limit
detect
assay
infect
cell
use
phenol
guanidin
isothiocyan
solut
trizol
sigma
isol
cytoplasm
rna
sarscov
infect
vero
cell
inocul
vero
cell
isol
rna
determin
sarscov
rna
abl
produc
cpe
cell
data
shown
also
found
transfect
cell
rna
use
liposomebas
transfect
reagent
dmriec
invitrogen
per
manufactur
instruct
rna
transfect
also
suffici
caus
infect
vero
cell
data
shown
addit
test
effect
treatment
inactiv
sarscov
briefli
sarscovinfect
vero
cell
lyse
solut
clarifi
centrifug
supernat
use
infect
vero
cell
monolay
cpe
observ
cell
day
indic
disrupt
virion
suffici
prevent
surviv
infecti
particl
inactiv
sarscov
achiev
number
techniqu
given
suffici
time
appropri
temperatur
condit
caution
inactiv
procedur
discuss
perform
specif
condit
due
grave
consequ
potenti
sarscov
human
infect
great
care
taken
ensur
inactiv
procedur
use
make
viru
safe
condit
effect
viral
stock
determin
greater
min
uvc
treatment
inactiv
viru
uva
light
effect
viabil
regardless
durat
exposur
duan
et
al
examin
effect
uvc
light
sarscov
intens
wcm
distanc
cm
determin
inactiv
viru
occur
min
inactiv
may
occur
effici
studi
due
greater
intens
uvc
light
closer
proxim
light
sourc
also
examin
effect
gamma
irradi
sarscov
found
decreas
infect
highest
dose
rad
result
surpris
center
diseas
control
prevent
use
much
higher
dose
rad
inactiv
potenti
sarscovinfect
serum
specimen
studi
laboratori
dosag
rang
rad
necessari
inactiv
virus
monoclon
antibodi
prepar
grieb
et
al
bone
diaphysi
transplant
pruss
et
al
experi
show
heat
treatment
sarscov
min
c
result
inactiv
viru
min
c
requir
viru
inactiv
laud
determin
thermal
inactiv
anoth
coronaviru
transmiss
gastroenter
viru
swine
also
occur
faster
higher
temperatur
c
lower
temperatur
c
data
similar
find
duan
et
al
wherein
viral
inactiv
occur
min
incub
c
respect
heat
effect
mean
sarscov
inactiv
howev
stock
contain
viral
aggreg
may
requir
longer
durat
heat
exposur
determin
formalin
glutaraldehyd
inactiv
sarscov
temperatureand
timedepend
manner
incub
c
inhibit
effect
chemic
c
room
temperatur
formalin
significantli
decreas
infect
viru
day
glutaraldehyd
inactiv
sarscov
incub
day
glutaraldehyd
commonli
use
disinfect
medic
instrument
especi
endoscop
care
taken
analyz
time
temperatur
concentr
requir
necessari
complet
sarscov
inactiv
weismil
et
al
determin
ph
induc
conform
chang
spike
protein
coronaviru
mhv
enabl
fusion
virion
host
cell
howev
xiao
et
al
determin
spike
protein
sarscov
mediat
fusion
host
cell
neutral
ph
data
suggest
differ
ph
condit
affect
spike
protein
coronavirus
activ
spike
protein
sarscov
may
sensit
chang
ph
possibl
chang
infecti
natur
viral
particl
determin
exposur
sarscov
extrem
basic
acid
condit
caus
inactiv
viru
remain
stabl
within
rang
neutral
ph
ph
gastric
secret
stomach
rang
small
larg
intestin
rang
ph
guyton
hall
taken
togeth
data
suggest
ingest
sarscov
would
probabl
result
inactiv
virion
stomach
acid
howev
acid
condit
stomach
may
partial
neutral
particularli
larg
meal
antacid
ingest
condit
viru
might
chanc
move
stomach
slightli
basic
condit
intestin
leung
et
al
shown
enter
involv
sar
viru
evidenc
presenc
activ
viral
replic
intestin
biopsi
specimen
five
patient
isol
sarscov
rna
stool
specimen
week
onset
symptom
data
coupl
previous
mention
stabil
viru
moder
ph
condit
suggest
sar
viru
may
surviv
ingest
fecalor
rout
infect
may
possibl
experi
show
uvc
light
heat
formalin
glutaraldehyd
extrem
ph
abl
inactiv
sarscov
howev
gamma
irradi
dose
test
suffici
inactiv
viru
expect
neither
viral
rna
alon
virion
disrupt
infecti
condit
appropri
viral
stock
describ
howev
caution
research
need
test
viral
stock
complet
inactiv
handl
viru
lower
safeti
level
data
analyz
viru
sampl
tissu
cultur
medium
current
test
inactiv
properti
requir
sarscov
biolog
bodi
fluid
understand
way
sarscov
inactiv
allow
transfer
viru
condit
promot
studi
inactiv
viral
vaccin
